切换至 "中华医学电子期刊资源库"

中华消化病与影像杂志(电子版) ›› 2018, Vol. 08 ›› Issue (04) : 173 -177. doi: 10.3877/cma.j.issn.2095-2015.2018.04.008

所属专题: 文献

综述

腹泻型肠易激综合征与显微镜下结肠炎的诊治进展
李桂红1, 晏喻婷1, 蒋波涛1,()   
  1. 1. 400711 广州中医药大学附属重庆市北碚中医院消化科
  • 收稿日期:2018-01-04 出版日期:2018-08-01
  • 通信作者: 蒋波涛

Advances in diagnosis and treatment of diarrhea-predominant irritable bowel syndrome and microscopic colitis

Guihong Li1, Yuting Yan1, Botao Jiang1,()   

  1. 1. Department of Gastroenterology, Guangzhou University of Chinese Medicine Affiliated Chongqing Beibei Hospital of Traditional Chinese Medicine, Chongqing 400711, China
  • Received:2018-01-04 Published:2018-08-01
  • Corresponding author: Botao Jiang
  • About author:
    Corresponding author: Jiang Botao, Email:
引用本文:

李桂红, 晏喻婷, 蒋波涛. 腹泻型肠易激综合征与显微镜下结肠炎的诊治进展[J]. 中华消化病与影像杂志(电子版), 2018, 08(04): 173-177.

Guihong Li, Yuting Yan, Botao Jiang. Advances in diagnosis and treatment of diarrhea-predominant irritable bowel syndrome and microscopic colitis[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2018, 08(04): 173-177.

腹泻型肠易激综合征(diarrhea-predominant irritable bowel syndrome,IBS-D)与显微镜下结肠炎(microscopic colitis,MC)在临床表现上均为反复发作的、非出血性、水样或稀糊状腹泻,且结肠镜检查均为正常黏膜像,但二者却为不同性质的2种疾病。IBS-D的诊断是基于症状学基础的罗马Ⅲ标准,MC的确诊方法是结肠镜下结肠黏膜组织活检。由于IBS-D与MC在临床症状上的重叠和阴性结肠镜表现,极易造成二者之间的误诊。目前全球尚无统一的MC诊断共识,国内的临床医师对MC的认识不足、结肠镜下黏膜活检率低,造成MC临床极高的误诊率。本文从IBS-D和MC的流行病学、病因、临床症状、诊断、治疗,及其临床症状重叠情况的研究进展进行综述。

The diarrhea-predominant irritable bowel syndrome(IBS-D)and microscopic colitis(MC)are recurrent, non hemorrhagic, water or dilute diarrhea in the clinical manifestations, and the colonoscopy shows normal mucosa.But the two are two diseases of different nature.The diagnosis of IBS-D is based on the Rome Ⅲ standard based on symptomatology.The diagnostic method of MC is colonoscopic colonic mucosa biopsy.Because of the overlap of clinical symptoms and negative colonoscopy between IBS-D and MC, it is easy to cause misdiagnosis.At present, there is no unified consensus on MC diagnosis in the world.The lack of understanding of MC by clinicians in China and the low rate of mucosal biopsy under colonoscopy cause the high misdiagnosis rate of MC.This paper makes a review of the research progress of epidemiology, etiology, clinical symptoms, diagnosis, treatment and clinical symptoms overlap of IBS-D and MC.

1
Kamp EJCA, Kane JS, Ford AC.Irritable bowel syndrome and microscopic colitis: a systematic review and meat-analysis[J]. Clin Gastroenterol Hepatol, 2016, 14(5): 659-668.
2
Lovell RM, Ford AC.Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis[J]. Clin Gastroenterol Hepatol, 2012, 10(7): 712-721.
3
Sperber AD, Dumitrascu D, Fukudo S, et al.The global prevalence of IBS in adults remains elusive due to the heterogeneity of studies: a Rome Foundation working team literature review[J]. Gut, 2017, 66(6): 1075-1082.
4
张璐,段丽萍,刘懿萱,等.中国人群肠易激综合征患病率和相关危险因素的Meta分析[J].中华内科杂志, 2014, 53(12): 969-975.
5
Zhao YF, Guo XJ, Zhang ZS, et al.Epidemiology of Functional Diarrhea and Comparison with Diarrhea-Predominant Irritable Bowel Syndrome: A Population-Based Survey in China[J]. PLoS One, 2012, 7 (8): 906-907.
6
Lindström CG.'Collagenous colitis’ with watery diarrhea-a new entity?[J]. Pathol Eur, 1976, 11(1): 87-89.
7
Lazenby AJ, Yardley JH, Giardiello FM, et al.Lymphocytic ( "microscopic" ) colitis: a comparative histopathologic study with particular reference to collagenous colitis[J]. Hum Pathol, 1989, 20(1): 18-28.
8
Johan Bohr, Anna wickbom, Agnes Hegedus, et al.Diagnosis and management of microscopic colitis: Current perspectives[J]. Clin Exp Gastroenterol, 2014, 21(7): 273-284.
9
Pardi DS, Tremaine WJ, Carrasco-Labra A. American Gastroenterological Association institute technical review on the medical management of microscopic colitis[J]. Gastroenterology, 2016, 150(1): 247-274.
10
Pardi DS.Diagnosis and Management of Microscopic Colitis[J]. Am J Gastroenterol, 2017, 112 (1): 78-85.
11
Williams JJ, Kaplan GG, Makhija S, et al.Microscopic colitis-defining incidence rates and risk factors: a population-based study[J]. Clin Gastroenterol Hepatol, 2008, 6(1): 35-40.
12
Tong J, Zheng Q, Zhang C, et al.Incidence, prevalence, and temporal trends of microscopic colitis: a systematic review and meta-analysis[J]. Am J Gastroenterol, 2015, 110(2): 265-276.
13
Gu HX, Zhi FC, Huang Y, et al.Microscopic colitis in patients with chronic diarrhea and normal colonoscopic findings in Southern China[J]. Int J Colorectal Dis, 2012, 27(9): 1167-1173.
14
汤辉,田久林,蒋波涛,等.显微镜结肠炎的诊疗进展[J].世界华人消化杂志, 2017, 25(14): 1272-1278.
15
Spiller R, Aziz Q, Creed F, et al.Guidelines on the irritable bowel syndrome: mechanisms and practical management[J]. Gut, 2007, 56(12): 1770-1798.
16
中华医学会消化病学分会胃肠功能性疾病协作组.中国肠易激综合征专家共识意见[J].中华消化杂志, 2016, 36 (5): 299-312.
17
Koskela RM, Karttunen TJ, Niemelä SE, et al.Human leucocyte antigen and TNFalpha polymorphism association in microscopic colitis[J]. Eur J Gastroenterol Hepatol, 2008, 20(4): 276-282.
18
Roth B, Gustafsson RJ, Ohlsson B. Auto-antibodies and their association with clinical findings in women diagnosed with microscopic colitis[J]. PLoS One, 2013, 8(6): e66088.
19
Beaugerie L, Pardi DS.Review article: drug-induced microscopic colitis-proposal for a scoring system and review of the literature[J]. Aliment Pharmacol Ther, 2005, 22(4): 277-284.
20
Fernández-Bañares F, de Sousa MR, Salas A, et al.Impact of current smoking on the clinical course of microscopic colitis[J]. Inflamm Bowel Dis, 2013, 19(7): 1470-1476.
21
Ung KA, Gillberg R, Kilander A, et al.Role of bile acids and bile acid binding agents in patients with collagenous colitis[J]. Gut, 2000, 46(2): 170-175.
22
Aigner T, Neureiter D, Müller S, et al.Extracellular matrix composition and gene expression in collagenous colitis[J]. Gastroenterology, 1997, 113(1): 136-143.
23
Helal TE, Ahm ed NS, El Fotoh OA.Lymphocytic colitis: a clue to bacterial etiology[J]. World J Gastroenterol, 2005, 11(46): 7266-7271.
24
Zhu L, Huang D, Shi L, et al.Intestinal symptoms and psychological factors jointly affect quality of life of patients with irritable bowel syndrome with diarrhea[J]. Health Qual Life Outcomes, 2015, 13: 49.
25
Canavan C, Card T, West J, et al.The Incidence of Other Gastroenterological Disease following Diagnosis of Irritable Bowel Syndrome in the UK: A Cohort Study[J]. PLoS One, 2014, 9(9): e106478.
26
Longestreth GF, Yao JF.Irritable bowel syndrome and surgery: a multivariable analysis[J]. Gastroenterology, 2004, 126(7): 1665-1673.
27
Gentile N, Yen EF.Prevalence, Pathogenesis, Diagnosis, and Management of Microscopic Colitis[J]. Gut Liver, 2018, 12(3): 227-235.
28
Tontini GE, Pastorelli L, Spina L, et al.Microscopic colitis and colorectal neoplastic lesion rate in chronic nonbloody diarrhea: a prospective, multicenter study[J]. Inflamm Bowel Dis, 2014, 20(5): 882-891.
29
Storr MA.Microscopic colitis: epidemiology, pathophysiology, diagnosis and current managemen-an update 2013[J]. ISRN Gastroenterol, 2013, 2013: 352718.
30
Stoicescu A, Becheanu G, Dumbrava M, et al.Microscopic colitis-a missed diagnosis in diarrhea-predominant irritable bowel syndrome[J]. Mdica, 2012, 7 (1): 3-9.
31
Longstreth GF, Thompson WG, Chey WD, et al.Functional bowel disorders[J]. Gastroenterology, 2006, 130(5): 1480-1491.
32
Ford AC, Moayyedi P, Lacy BE, et al.American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation[J]. Am J Gastroenterol, 2014, 109 Suppl 1: S2-S26.
33
Münch A, Langner C. Microscopic colitis: clinical and pathologic perspectives[J]. Clin Gastroenterol Hepatol, 2015, 13(2): 228-236.
34
Weinberg DS, Smalley W, Heidelbaugh JJ, et al.American Gastroenterological Association Institute Guideline on the Pharmacological Management of Irritable Bowel Syndrome[J]. Gastroenterology, 2014, 147(5): 1146-1148.
35
Lembo AJ, Lacy BE, Zuckerman MJ, et al.Eluxadoline for irritable bowel syndrome with diarrhea[J]. N Engl J Med, 2016, 374(3): 242-253.
36
Nguyen GC, Smalley WE, Vege SS, Carrasco-Labra A, Clinical Guidelines Committee.American Gastroenterological Association Institute Guideline on the Medical Management of Microscopic Colitis[J]. Gastroenterology, 2016, 150(1): 242-246.
37
Münch A, Aust D, Bohr J, et al.Microscopic colitis: Current status, present and future challenges: statements of the European Microscopic Colitis Group[J]. J Crohns Colitis, 2012, 6(9): 932-945.
38
Bonderup OK, Hansen JB, Teglbjaerg PS, et al.Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trial[J]. Gut, 2009, 58(1): 68-72.
39
Miehlke S, Madisch A, Kupcinskas L, et al.Budesonide is more effective than mesalamine or placebo in short-term treatment of collagenous colitis[J]. Gastroenterology, 2014, 146(5): 1-2.
40
Gralnek IM, Hays RD, Kilbourne A, et al.The impact of irritable bowel syndrome on health-related quality of life[J]. Gastroenterology, 2000, 119(3): 654-660.
41
Ghoshal UC, Gwee KA, Chen M, et al.Development, translation and validation of enhanced Asian Rome Ⅲ questionnaires for diagnosis of functional bowel diseases in major asian languages: a Rome foundation Asian neurogastroenterology and motility association working team report[J]. J Neurogastroenterol Motil, 2015, 21(1): 83-92.
42
Hilpüsch F, Johnsen PH, Goll R, et al.Microscopic colitis: a missed diagnosis among patients with moderate to severe irritable bowel syndrome[J]. Scand J Gastroenterol, 2017, 52 (2): 173.
43
Guagnozzi D, Ariasá, Lucendo AJ.Systematic review with meta-analysis: diagnostic overlap of microscopic colitis and functional bowel disorders[J]. Aliment Pharmacol Ther, 2016, 43 (8): 851-862.
44
Limsui D, Pardi DS, Camilleri M, et al.Symptomatic overlap between irritable bowel syndrome and microscopic colitis[J]. Inflamm Bowel Dis, 2010, 13(2): 175-181.
45
Macaigne G, Lahmek P, Locher C, et al.Microscopic colitis or functional bowel disease with diarrhea: a French prospective multicenter study[J]. Am J Gastroenterol, 2014, 109(9): 1461-1470.
46
Kane JS, Rotimi O, Everett SM, et al.Development and validation of a scoring system to identify patients with microscopic colitis[J]. Clin Gastroenterol Hepatol, 2015, 13(6): 1125-1131.
47
Olesen M, Eriksson S, Bohr J, et al.Microscopic colitis: a common diarrhoeal disease.An epidemiological study in Orebro, Sweden, 1993-1998[J]. Gut, 2004, 53(3): 346-350.
48
Jessurun J, Yardley JH, Lee EL, et al.Microscopic and collagenous colitis: di?erent names for the same condition?[J]. Gastroenterology, 1986, 91(6): 1583-1584.
49
Pokorny CS, Kneale KL, Henderson CJ.Progression of collagenous colitis to ulcerative colitis[J]. J Clin Gastroenterol, 2001, 32(5): 435-438.
[1] 李全喜, 唐辉军, 唐友杰, 杨飞. DISCO成像技术在前列腺增生与前列腺癌鉴别诊断中的应用价值[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 332-335.
[2] 胡月, 袁媛, 韩江英. 输尿管支架置入患者护理评估与干预研究进展[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(01): 86-89.
[3] 吴新兰, 余静. 彩色多普勒超声在腹股沟斜疝和直疝与股疝鉴别诊断中的应用价值[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(05): 611-614.
[4] 张霄峰, 王军. 腹股沟疝与股疝的超声征象及鉴别诊断价值分析[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(05): 615-618.
[5] 罗桓, 王智园, 杨莹, 张映林, 黎贵芸, 李方方, 边莉. 胸壁黏液炎性纤维母细胞肉瘤一例[J]. 中华肺部疾病杂志(电子版), 2023, 16(01): 128-131.
[6] 徐冰, 程明斌, 赵国华. CT影像学征象对局灶性肺炎型肺癌与肺部炎性病变的鉴别意义[J]. 中华肺部疾病杂志(电子版), 2023, 16(01): 58-60.
[7] 朱风尚, 舍玲, 丁永年, 杨长青. 警惕炎症性肠病与少见肠道疾病的鉴别诊断[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 273-276.
[8] 吴枫, 刘晓璐, 王谦, 徐娟. 彩色多普勒超声对胃间质瘤的诊断价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(04): 229-231.
[9] 李玮佳, 李振方, 李聪, 张倩, 赵琦. 胃食管阀瓣分级在伴有食管外症状的反流性食管炎的分布特点及意义[J]. 中华消化病与影像杂志(电子版), 2023, 13(02): 68-72.
[10] 史亚东, 顾建平. 无症状肺栓塞的诊断与治疗进展[J]. 中华介入放射学电子杂志, 2023, 11(02): 155-158.
[11] 赵键, 孙法同, 邢宝杰, 王勇, 吕琳, 于雪淳, 王海滨, 贾代良. 肢体坏死性筋膜炎的诊断学特征并文献复习[J]. 中华诊断学电子杂志, 2023, 11(02): 87-91.
[12] 周晓晴, 宁波, 令狐恩强. 肠系膜脂膜炎临床诊治的研究进展[J]. 中华胃肠内镜电子杂志, 2023, 10(04): 267-270.
[13] 张继舜, 陈思旭, 钱洁, 尚占民, 郝建宇. 平均夜间基线阻抗对食管外症状胃食管反流病的临床诊断价值[J]. 中华胃肠内镜电子杂志, 2023, 10(02): 97-102.
[14] 陈升鑫, 翟亚奇, 卜保国, 陈德鑫, 吴浪, 方开萱, 刘文静, 李明阳, 令狐恩强. 自身免疫性胰腺炎临床特征分析[J]. 中华胃肠内镜电子杂志, 2023, 10(01): 46-51.
[15] 闫晶, 蒋媛, 买买提·依斯热依力, 王俭, 王永康, 阿巴伯克力·乌斯曼, 王志, 克力木·阿不都热依木. 膈肌生物反馈训练对胃食管反流病的效果分析[J]. 中华胃食管反流病电子杂志, 2023, 10(01): 50-55.
阅读次数
全文


摘要